This report explores the growing influence of GLP-1 medications on food and drink consumption, assessing whether these drugs will disrupt established dietary habits or open new opportunities for product innovation.
Already a subscriber? Log in to download
About this report
How This Report Can Benefit the Industry:
Identifies the scale and nature of GLP-1’s disruption across the FMCG industry.
Helps brands understand how reduced appetite, lifestyle changes, and new priorities shape product demand, helping guide innovation.